Haemonetics Corporation

Healthcare

NYSE:HAE · New York Stock Exchange

Market Cap $3.55B Beta 0.54 P/E (TTM) 37.1

$78.20 -2.05%

-$1.64 today

52W Low $47.32High $87.32

Vol 1.05M · Avg 0.84M

EPS (TTM)$2.11

Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+11.57%

Period High

$87.16

Period Low

$47.67

Latest

$78.20

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Catalyst Pharmaceuticals, Inc.

NASDAQ:CPRX

$3.84B

Concentra Group Holdings Parent, Inc.

NYSE:CON

$3.60B

Warby Parker Inc.

NYSE:WRBY

$3.25B

Integer Holdings Corporation

NYSE:ITGR

$3.09B

Beam Therapeutics Inc.

NASDAQ:BEAM

$2.99B

Premier, Inc.

PINC

$2.34B

LeMaitre Vascular, Inc.

NASDAQ:LMAT

$2.10B

DENTSPLY SIRONA Inc.

NASDAQ:XRAY

$2.02B

Bausch Health Companies Inc.

NYSE:BHC

$1.89B

QuidelOrtho Corporation

NASDAQ:QDEL

$963.54M

What is the latest HAE filing?

The latest filing shown is DEF 14A dated Jun 9, 2026.

How many recent filings does HAE have?

Intrinsic Alpha currently shows 20 recent filings for HAE.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.